NIPH Clinical Trials Search

A prospective observational study of EBV-HLH

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	EBV-HLH
Date of first enrollment	17/06/2025
Target sample size	75
Countries of recruitment
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	Relationship between clinical characteristics of newly diagnosed (including suspected cases) EBV-HLH and treatment options
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	< 40age old
Gender
Include criteria	Patients younger than 40 years with EBV-HLH (including suspected cases)
Exclude criteria	1. HCT-associated HLH 2. Macrophage activating syndrome (HLH associated with autoimmune diseases) 3. Malignancy-associated HLH